Event

Novel Therapeutics for Gastrointestinal Malignancies
Presented by the Surgical and Thoracic Oncology Divisions in Coordination with the Cancer Programs at Cooperman Barnabas Medical Center, RWJBarnabas Health

2 AMA PRA Category 1 Credits^TM

To promote evidence based advances in the screening, diagnosis and treatment of GI Cancer.

Target Audience
Internal Medicine, Family Practice, Gastroenterology, General Surgery, Medical Oncology, Radiation Oncology, Nurses and Allied Health Professionals.

Learning Objectives
Upon completion of this course, attendees should be able to:

• Identify the importance of a team approach to GI malignancies to ensure superior outcomes and survival.
• Appreciate the advancements in procedures, radiation oncology and systemic therapy.
• Recognize which patient populations may benefit from novel therapeutic interventions by improving appropriate referral for GI malignancies.
• Understand the American Joint Committee on Cancer (AJCC) pancreatic cancer staging updates.

Registration
There is no fee to participate in this symposium, but online registration is required by October 1, 2018.

Agenda
Wednesday, October 10, 2018; 6:00 to 8:30 pm -- Highlawn Pavilion, 1 Crest Drive, West Orange

6:00 pm
Registration and Reception

6:30 pm
Welcoming Introductory Remarks

6:45 pm
Dinner and Presentations

Moderator: Russell C. Langan, MD, Surgical Oncology & Hepatopancreatobiliary Surgery, Surgical Director, Comprehensive Liver Center, Cooperman Barnabas Medical Center; Assistant Professor of Surgery, Rutgers Cancer Institute of New Jersey, Robert Wood-Johnson University Medical School

Immunotherapy for GI Malignancies
Franz Smith, MD, Surgical Oncology, Director, Surgical Residency Program, Cooperman Barnabas Medical Center

State of the Art 2018: Radiation Therapy for Hepatobiliary Cancers
Raquel Wagman, MD, Radiation Oncologist, Director, Residency Program, Cooperman Barnabas Medical Center

Liver Directed Therapies in the Era of y90
Robert E. Kamieniecki, MD, Interventional Radiology, Cooperman Barnabas Medical Center

Cholangioscopy and Axios Stenting for Benign and Malignant Pancreatobiliary Disorders
David Rahni, MD, Gastroenterologist, Affiliates in Gastroenterology

Robotic Esophagectomy
Joanna Sesti, MD, Thoracic Surgeon, RWJBarnabas Health

Beyond Chemotherapy: Targeted Agents and Immunotherapy
Delia Radovich, MD, Medical Oncologist, Cooperman Barnabas Medical Center

Innovative Treatment Strategies for Hepatopancreatobiliary Malignancies
Russell C. Langan, MD, Surgical Oncology & Hepatopancreatobiliary Surgery, Surgical Director, Comprehensive Liver Center, Cooperman Barnabas Medical Center; Assistant Professor of Surgery, Rutgers Cancer Institute of New Jersey, Robert Wood-Johnson University Medical School

8:15 pm
Questions and Answers

Continuing Medical Education Credit
AMA Credit Designation Statement Cooperman Barnabas Medical Center designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accreditation Statement Cooperman Barnabas Medical Center is accredited by the Medical Society of New Jersey (MSNJ) to provide continuing medical education for physicians.
Disclosure Policy It is the policy of Cooperman Barnabas Medical Center, Office of Continuing Medical Education to ensure balance, independence, transparency, objectivity and scientific rigor in all CME sponsored educational activities. All participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict(s) of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussion of unlabeled or unapproved drugs or devises. This information will be available as part of the activity material.
Faculty Disclosures: No relevant financial relationship(s)
Acknowledgement of Commercial Support: No commercial support was provided for this continuing educational activity.
“Patient Safety Committee Work Product - Confidentiality Protection and Restrictions on Disclosure Pursuant to N.J.S.A. 26:2H -12.25b. & N.J.A.C. 8:43E-10.0”

Nursing Credit
Cooperman Barnabas Medical Center is an approved provider of continuing nursing education by New Jersey State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission On Accreditation. Provider # 151-8/14-17. Contact hours will be provided.